Carmine Stengone
Förmögenhet: 205 079 $ per 2026-05-31
Förmögenhet: 205 079 $ per 2026-05-31
Mr. Carmine N.
Stengone is an Independent Director at Kiora Pharmaceuticals, Inc. and a President, Chief Executive Officer & Director at Contineum Therapeutics, Inc. He is on the Board of Directors at Kiora Pharmaceuticals, Inc. and Contineum Therapeutics, Inc. Mr. Stengone was previously employed as a Senior Vice President-Business Development by COI Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by Avelas Biosciences, Inc., a President, Chief Executive Officer & Director by Afraxis, Inc., a Senior Director-Business Development by Phenomix Corp., a Senior Manager-Strategic Marketing by Anadys Pharmaceuticals, Inc., and a Principal by Johnson & Johnson Pharmaceutical Research & Development LLC.
He received his undergraduate degree from Wake Forest University, a graduate degree from Duke University and an MBA from Johnson Graduate School of Management.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-17 | 14 954 ( 0,05 % ) | 201 729 $ | 2026-05-31 | |
| 2026-06-10 | 1 250 ( 0,03 % ) | 3 350 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Verkställande Direktör | 2018-10-01 |
| KIORA PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2023-08-01 |
| Företag | Position | Slut |
|---|---|---|
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Develops integrated suite of therapeutic and imaging agents for treatment of cancer | Verkställande Direktör | 2018-01-01 |
COI Pharmaceuticals, Inc.
COI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides life science inventors with an environment where entrepreneurial and scientific risks are encouraged and rewarded | Företagsledare/Principal | 2018-10-01 |
Phenomix Corp.
Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Företagsledare/Principal | 2010-10-28 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Försäljning & Marknadsföring | 2006-01-01 |
Johnson & Johnson Pharmaceutical Research & Development LLC
Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides providing research and development support services | Företagsledare/Principal | 2004-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 11 |
|---|---|
Phenomix Corp.
Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Health Technology |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
Kiora Pharmaceuticals, Inc.
Kiora Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases | Health Technology |
Afraxis, Inc.
Afraxis, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of fragile X syndrome and autism | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wake Forest University
Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson & Johnson Pharmaceutical Research & Development LLC
Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides providing research and development support services | Commercial Services |
Johnson Graduate School of Management
Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Develops integrated suite of therapeutic and imaging agents for treatment of cancer | Health Services |
COI Pharmaceuticals, Inc.
COI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides life science inventors with an environment where entrepreneurial and scientific risks are encouraged and rewarded | Health Technology |
Pipeline Therapeutics, Inc.
Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån